Work

Genetics are not likely to offer clinically useful predictions for elevated liver enzyme levels in patients using low dose methotrexate

Year: 2022

Type: article

Source: Seminars in Arthritis and Rheumatism

DOI: 10.1016/j.semarthrit.2022.152036

Authors: Jing Cui, Daniel I. Chasman, Soumya Raychaudhuri, Chang Xu, Paul M. Ridker, Daniel H. Solomon, Elizabeth W. Karlson

Institution: Brigham and Women's Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, Biogen, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state, Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study, G5520316217, G5981859630, G8644708755, G9000000490, G9000105629, G9000286667, Joint Biology Consortium Resource-based Center, G932915660

OpenAlex ID: W4281736099

FWCI: 0.195

Cites: 34

Cited by: 3

Related to: 10